StratDeck

Two stocks in Healthcare

Fresenius Medical Care vs Novartis: profit, growth, debt and price compared

Fresenius Medical Care and Novartis are each stronger on 3 of 7 figures: Fresenius Medical Care on debt, price for its expected profit and dividend; Novartis on profit margin, sales growth and price trend.

Figures as of 18 November 2026Yahoo Finance
Explore Fresenius Medical Care's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Fresenius Medical Care and Novartis side by side
Fresenius Medical CareFME.DENovartisNOVN.SW
Net margin4.2%Stronger: 17.5%
Revenue growth, past year+1.10%Stronger: +4.70%
Debt to equityStronger: 79.2%128.6%
Forward P/EStronger: 10.1×15.9×
Dividend yieldStronger: 3.74%2.78%
AnalystsHold · 17Hold · 22
From its 200-day average−3.1%Stronger: +9.2%

Share price over the past year

  • Fresenius Medical Care−2.7%
  • Novartis+30.9%

20 Nov 202518 Nov 2026

Fresenius Medical Care or Novartis: which is stronger?

  • NOVN.SW

    Which is more profitable?

    Novartis keeps more of each sale as profit: 17.5% against 4.2%.

  • NOVN.SW

    Which is growing its sales faster?

    Novartis is growing its sales faster: +4.70% over the past year, against +1.10%.

  • FME.DE

    Which has borrowed less?

    Fresenius Medical Care has borrowed less: its debt is 79.2% of what its shareholders own, against 128.6% for Novartis.

  • FME.DE

    Which costs less for the profit it is expected to make?

    Fresenius Medical Care costs less for the profit it is expected to make: 10.1× its forward earnings, against 15.9×.

  • FME.DE

    Which pays more in dividends?

    Fresenius Medical Care pays more back in dividends for what a share costs: 3.74% a year, against 2.78%.

  • Which do analysts rate higher?

    Analysts rate both the same: Hold.

  • NOVN.SW

    Which is in the stronger price trend?

    Novartis' price is in the stronger trend: 9.2% above its 200-day average, against 3.1% below.

What each company does

FME.DEFresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally.

Reports results on 23 February 2027

NOVN.SWNovartis

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Reports results on 3 February 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every European healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.